Chicago Atlantic Real Estate Finance, Inc. — Form 8-K Summary
Business context and reporting period
Filed February 8, 2022, reporting an event dated February 3, 2022. Chicago Atlantic Real Estate Finance, Inc. entered into a credit agreement to provide financing to FarmaceuticalRX LLC and certain subsidiaries. The company is an emerging growth company, and its common stock trades on Nasdaq under the symbol REFI.
Transaction and key financial terms
- Total loan commitment: $34 million.
- Total funded by all lenders: $34 million.
- Chicago Atlantic’s funded portion: $30 million.
- Chicago Atlantic Admin, LLC acts as agent, and Green Ivy Capital, LLC acts as lead arranger.
- Chicago Atlantic’s commitment is secured by liens on substantially all borrower assets, including real estate owned in Ohio.
The filing does not provide the loan’s interest rate, maturity, repayment schedule, covenants, fees, expected yield, or the company’s ownership percentage in the credit facility.
Financial performance and liquidity
This filing does not report revenue, net income, cash flow, margins, debt balances, liquidity measures, book value, or earnings guidance. The filing text does not provide a clear value for any such metric.
Material changes, outlook, and risks
- The material event is the origination and funding of the secured loan to FarmaceuticalRX and its subsidiaries.
- The collateral is concentrated in the borrowers’ assets, particularly Ohio real estate; repayment therefore depends on borrower performance and collateral value.
- The filing provides no management outlook, operating forecast, contingency disclosure, or discussion of credit quality, defaults, or expected loss provisions.
- A press release announcing the funding was issued February 8, 2022 and filed as Exhibit 99.1.
- No financial statements or pro forma financial information were included. The company stated that any required materials would be filed by amendment within 71 calendar days.
Key facts investors should verify
- Review the credit agreement for pricing, maturity, amortization, covenants, collateral coverage, guarantees, and default provisions.
- Assess FarmaceuticalRX’s financial condition, repayment capacity, regulatory environment, and operating risks.
- Verify the appraised value, lien priority, and enforceability of the Ohio real estate collateral.
- Monitor subsequent filings for required financial statements, pro forma information, credit performance, impairments, or amendments.
- Reconcile the February 3 event date with the February 8 press release and filing signature date.